These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6625954)

  • 21. Two antacid regimens in the treatment of chronic duodenal ulcer.
    Pan S; Liao CH
    Taiwan Yi Xue Hui Za Zhi; 1984 Apr; 83(4):373-80. PubMed ID: 6589357
    [No Abstract]   [Full Text] [Related]  

  • 22. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
    Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antacids on intragastric pH in healthy subjects and duodenal ulcer patients. Influence of the size of the antacid dose and of anticholinergics.
    Uusitalo A; Keyriläinen O
    Clin Physiol; 1983 Dec; 3(6):503-11. PubMed ID: 6686808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying.
    Deering TB; Carlson GL; Malagelada JR; Duenes JA; McCall JT
    Gastroenterology; 1979 Nov; 77(5):986-90. PubMed ID: 39873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous omeprazole on twenty-four-hour intragastric pH in patients with a history of peptic ulcer. Comparison of two four-dosage regimens.
    Kiilerich S; Elsborg L
    Digestion; 1991; 48(2):75-80. PubMed ID: 1868973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a new antacid on basal and meal-stimulated gastric secretion.
    Sun DC; Rider JA
    Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):283-8. PubMed ID: 27093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antacid therapy for duodenal and gastric ulcer: the experience in the United States.
    Ippoliti AF
    Scand J Gastroenterol Suppl; 1982; 75():82-5. PubMed ID: 6755655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antacid and placebo produced similar pain relief in duodenal ulcer patients.
    Sturdevant RA; Isenberg JI; Secrist D; Ansfield J
    Gastroenterology; 1977 Jan; 72(1):1-5. PubMed ID: 318577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antacid therapy of duodenal ulcer. Effects of smaller doses.
    Berstad A
    Scand J Gastroenterol Suppl; 1982; 75():97-9. PubMed ID: 6128786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the acid neutralizing effects of a combination of antacid plus oxethazaine (Oxaine M) compared to antacid alone (Aludrox) in duodenal ulcer patients.
    Novaes CC; Richards DJ; Davis GR
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):124-31. PubMed ID: 240648
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers.
    Améndola R; Santos MC; Massa JM; Vazquez H; Smecuol E
    Acta Gastroenterol Latinoam; 2007 Dec; 37(4):231-7. PubMed ID: 18254261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of 3 therapeutic schemes on the pH of gastric contents in patients with duodenal ulcer].
    Bicalho SA; Ribeiro Tde C; Pessoa W; Castro Lde P
    AMB Rev Assoc Med Bras; 1979 Jun; 25(6):190-4. PubMed ID: 316152
    [No Abstract]   [Full Text] [Related]  

  • 33. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antacid pharmacology in duodenal ulcer. Effect of antacids on postcibal gastric acidity and peptic activity.
    Fordtran JS; Collyns JA
    N Engl J Med; 1966 Apr; 274(17):921-7. PubMed ID: 5908884
    [No Abstract]   [Full Text] [Related]  

  • 35. A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound.
    Texter EC
    Am J Gastroenterol; 1989 Feb; 84(2):97-108. PubMed ID: 2644821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acid-suppression profile of two continuously infused intravenous doses of cimetidine.
    Karlstadt RG; Hedrich DA; Asbel-Sethi NR; Palmer RH
    Clin Ther; 1993; 15(1):97-106. PubMed ID: 8458059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose antacid therapy in the treatment of duodenal ulcer--a multicentre double-blind trial vs. misoprostol.
    Caspary WF; Hengels KJ; Kunert H; Rösch W; Rohner HG; Spuhler S; Nauert C
    Z Gastroenterol; 1991 Sep; 29(9):411-6. PubMed ID: 1763561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single intragastric pH electrode does not accurately measure intragastric acidity.
    Fisher RS; Sher DJ; Donahue D; Senior J; Krevsky B
    Am J Gastroenterol; 1996 Jun; 91(6):1167-72. PubMed ID: 8651165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute relief of epigastric pain by antacid in duodenal ulcer patients.
    Rune SJ; Zachariassen A
    Scand J Gastroenterol Suppl; 1980; 58():41-5. PubMed ID: 6988941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastrobulbar pH during combination antacid therapy in bulbar ulcers].
    Dolinský A
    Vnitr Lek; 1978 Jun; 24(6):608-13. PubMed ID: 27899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.